Drug
Relaxin clinical trials
- studies test it
- 6
- open now
- 1
- in phase 3
- 2
- first study started
- 1991
Keep track of what changes. Save the Relaxin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
5 studies that test it; most in 1991 (1); 1 more planned to start later
| Year | Studies |
|---|---|
| 1991 | 1 |
| 1998 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 5
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 4
Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies (2) · Cambridge University Hospitals NHS Foundation Trust (1) · University of Medicine and Dentistry of New Jersey (1) · National Center for Research Resources (NCRR) (1) · Deeptankar DeMazumder (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Relaxin is read from its arms, and is right about nine times in ten.
Testing it · 6
- Relaxin Therapy for Atrial FibrillationNot yet recruitingPhase 1/2Deeptankar DeMazumderNCT07359872Written as Relaxin
- A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxinActive, not recruitingPhase 2Cambridge University Hospitals NHS Foundation TrustNCT03449251Written as Relaxin
- Efficacy and Safety of Relaxin for the Treatment of Acute Heart FailureCompletedPhase 2/3Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companiesNCT00520806Written as Relaxin
- A Pilot Study of Recombinant Human Relaxin (rhRlx) in Compensated Congestive Heart FailureCompletedPhase 2Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companiesNCT00259116Written as Relaxin
- Recombinant Human Relaxin in the Treatment of Diffuse SclerodermaCompletedPhase 3University of Medicine and Dentistry of New JerseyNCT00704665Written as Relaxin
- Phase II Study of Recombinant Relaxin for Progressive Systemic SclerosisCompletedPhase 2National Center for Research Resources (NCRR)NCT00004380Written as relaxin